journal article·2017Open access

Comparison of Compression and Material Properties of Differently Shaped and Sized Paracetamols

Michal Šimek, Veronika Grünwaldová, Bohumil Kratochvíl

KONA Powder and Particle Journal· Volume 34· Issue 0

Abstract

Paracetamol is well-known API (active pharmaceutical ingredient) for its bad flow and compression abilities. To improve the compressibility, a high amount of excipient is commonly mixed with paracetamol to create better compressible material. Conversely, we used modified crystallization procedures to prepare plate, irregular and spherical particles from original raw paracetamol to prepare directly compressible API. To expand our screening, several sizes of each shape were prepared and material properties analyzed, mainly the flow and compression abilities, and significant variation of the properties presented; from very poor properties of raw paracetamol to excellent properties of spherical crystals which exhibited ability to be directly compressed without excipient. The analysis also showed very small effect of the size modification on tablet compression and material behavior as the main contribution had the shape alteration and compression force.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Drug Solubulity and Delivery Systems · Crystallization and Solubility Studies · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Solid State Chemistry, University of chemistry and technology Prague, Czech Republic

Zentiva k.s., Czech Republic

Funding

Ministry of Education, Youth and Sports of the Czech Republic

References (20)

Show source-provided references
1. Aghababian R.V., Essentials of emergency medicine, Jones and Bartlett Publishers, 2010.
2. Ahmad J., Hepatology and Transplant Hepatology: A Case Based Approach, Springer, 2010.10.1007/978-1-4419-7085-5 ↗
3. Armstrong N.A., Haines-Nutt R.F., Elastic recovery and surface area in compacted powder systems, J. Pharm. Pharmacol., 24 (1972) 135–136.
4. Di Martino P., Guyot-Hermann A.-M., Conflant P., Drache M., Guyot J.-C., A new pure paracetamol for direct compression: the orthorhombic form, Int. J. Pharm., 128 (1996) 1–8.10.1016/0378-5173(95)04127-3 ↗
5. El-Zhry El-Yafi A.K., El-Zein H., Technical crystallization for application in pharmaceutical material engineering: Review article, Asian Journal of Pharmaceutical Sciences, 10 (2015) 283–291.10.1016/j.ajps.2015.03.003 ↗
6. European Medicines Agency, European Pharmacopoeia—Part EP 2.9.34. Bulk density and tapped density of powders, 2006a.
7. European Medicines Agency, European Pharmacopoeia—Part EP 2.9.36. Angle of repose, 2006b.
8. Garekani H.A., Ford J.L., Rubinstein M.H., Rajabi-Siahboomi A.R., Formation and compression characteristics of prismatic polyhedral and thin plate-like crystals of paracetamol, Int. J. Pharm., 187 (1999) 77–89.10.1016/S0378-5173(99)00157-X ↗
9. Garekani H.A., Ford J.L., Rubinstein M.H., Rajabi-Siahboomi A.R., Highly compressible paracetamol: I: crystallization and characterization, Int. J. Pharm., 208 (2000) 87–99.10.1016/S0378-5173(00)00550-0 ↗
10. Gibson M., Pharmaceutical Preformulation and Formulation, 2, Informa Healthcare USA, Inc., New York, 2009.
11. Gonda I., Development of a systematic theory of suspension inhalation aerosols. I. A framework to study the effects of aggregation on the aerodynamic behaviour of drug particles, International Journal of Pharmaceutics, 27 (1985) 99–116.10.1016/0378-5173(85)90189-9 ↗
12. Gordon R.E., Amin S.I., Crystallization of ibuprofen, Google Patents, 1984.
13. Jordens J., Gielen B., Braeken L., Van Gerven T., Determination of the effect of the ultrasonic frequency on the cooling crystallization of paracetamol, Chemical Engineering and Processing: Process Intensification, 84 (2014) 38–44.10.1016/j.cep.2014.01.006 ↗
14. Kaialy W., Larhrib H., Chikwanha B., Shojaee S., Nokhodchi A., An approach to engineer paracetamol crystals by antisolvent crystallization technique in presence of various additives for direct compression, Int J Pharm, 464 (2014) 53–64.10.1016/j.ijpharm.2014.01.026 ↗
15. Lacmann R., Crystallization, Third Edition. J.W. Mullin, Butterworth-Heinemann, Oxford 1997, 527 Seiten, zahlr. Abb. und ISBN 0-7506-3759-5, Chemie Ingenieur Technik, 70 (1998) 1468–1468.10.1002/cite.330701126 ↗
16. Marshall P.V., York P., Crystallisation solvent induced solid-state and particulate modifications of nitrofurantoin, International Journal of Pharmaceutics, 55 (1989) 257–263.10.1016/0378-5173(89)90049-5 ↗
17. Marshall P.V., York P., The compaction properties of nitrofurantoin samples crystallised from different solvents, International Journal of Pharmaceutics, 67 (1991) 59–65.10.1016/0378-5173(91)90265-P ↗
18. Ó’Ciardhá C.T., Frawley P.J., Mitchell N.A., Estimation of the nucleation kinetics for the anti-solvent crystallisation of paracetamol in methanol/water solutions, Journal of Crystal Growth, 328 (2011) 50–57.10.1016/j.jcrysgro.2011.06.017 ↗
19. Šimek M., Grünwaldová V., Kratochvíl B., Hot-stage microscopy for determination of API fragmentation: comparison with other methods, Pharm. Dev. Technol., in press (2015)10.3109/10837450.2015.1026608 ↗
20. York P., Solid-state properties of powders in the formulation and processing of solid dosage forms, International Journal of Pharmaceutics, 14 (1983) 1–28.10.1016/0378-5173(83)90111-4 ↗